15 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp00306 | Temporin-SHf | FFFLSRIF* | Sahara frog | Apoptosis inducing | MTT assay | PC3 | Not specified | IC50 : 36.67 ± 0.729 µM |
| dbacp00820 | AaeAP1 | FLFSLIPSVIAGLVSAIRN | Aeneas fattailed scorpion | Not specified | MTT assay | PC3 | Prostate cancer | Not found |
| dbacp00828 | AaeAP2 | FLFSLIPSAIAGLVSAIRN | Aeneas fattailed scorpion | Not specified | MTT assay | PC3 | Prostate cancer | Not found |
| dbacp01171 | Antimicrobial peptide TsAP-5 | MQIKHLITIFFLVLIVADHCHAFLGMIPGLIGGLISAFKGRRKREITSQIEQYRNLQKREAELENLLANLPVY | Brazilian scorpion | Antiproliferative activity | Not specified | PC3 | Prostate cancer | IC50 : 13.3 μM |
| dbacp02726 | Dermaseptin-PS3 | ALWKDILKNAGKAALNEINQIVQ | Skin, the waxy monkey tree frog, South America | Membrane rupture | MTT assay | PC3 | Human prostate carcinoma | IC50 : 18.20 μM |
| dbacp02742 | Dermaseptins B2 | GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV-NH2 | Giant leaf frog | Interact with the lipids of the plasma membrane | In vitro proliferation assay, Lactate dehydrogenase (LDH)-release assay | PC3 | Human breast cancer | GI50 : 2.17 ± 0.48 μM |
| dbacp02781 | Distinctin-Like-Peptide-PH | NLVSALIEGRKYLKNVLKKLNRLKEKNKAKNSKENN | Skin Secretion, Northern orange-legged leaf frog, South America | Membrane lysis via pore formation | MTT Cell viability assay, LDH assay | PC3 | Lung cancer | MIC : ≥ 4.197 μM |
| dbacp02782 | Distinctin-Like-Peptide-PH | NLVSALIEGRKYLKNVLKKLNRLKEKNKAKNSKENN | Skin Secretion, Northern orange-legged leaf frog, South America | Membrane lysis via pore formation | MTT Cell viability assay, LDH assay | PC3 | Lung cancer | IC50 : 32.25 μg/mL |
| dbacp04596 | Mauriporin (Non-disulfide-bridged peptide 2.8) (NDBP-2.8) | MNKKTLLVIFFITMLIVDEVNSFKIGGFIKKLWRSKLAKKLRAKGRELLKDYANRVINGGPEEEAAVPAERRR | Fat-tailed scorpion | Anti-proliferative action | Not specified | PC3 | Prostate cancer | IC50 : 7.7 μM |
| dbacp04829 | Neuropilin-1 | MERGLPLLCAVLALVLAPAGAFRNDKCGDTIKIESPGYLTSPGYPHSYHPSEKCEWLIQAPDPYQRIMINFNPHFDLEDRDCKYDYVEVFDGENENGHFRGKFCGKIAPPPVVSSGPFLFIKFVSDYETHGAGFSIRYEIFKRGPECSQNYTTPSGVIKSPGFPEKYPNSLECTYIVFVPKMSEIILEFESFDLEPDSNPPGGMFCRYDRLEIWDGFPDVGPHIGRYCGQKTPGRIRSSSGILSMVFYTDSAIAKEGFSANYSVLQSSVSEDFKCMEALGMESGEIHSDQITASSQYSTNWSAERSRLNYPENGWTPGEDSYREWIQVDLGLLRFVTAVGTQGAISKETKKKYYVKTYKIDVSSNGEDWITIKEGNKPVLFQGNTNPTDVVVAVFPKPLITRFVRIKPATWETGISMRFEVYGCKITDYPCSGMLGMVSGLISDSQITSSNQGDRNWMPENIRLVTSRSGWALPPAPHSYINEWLQIDLGEEKIVRGIIIQGGKHRENKVFMRKFKIGYSNNGSDWKMIMDDSKRKAKSFEGNNNYDTPELRTFPALSTRFIRIYPERATHGGLGLRMELLGCEVEAPTAGPTTPNGNLVDECDDDQANCHSGTGDDFQLTGGTTVLATEKPTVIDSTIQSEFPTYGFNCEFGWGSHKTFCHWEHDNHVQLKWSVLTSKTGPIQDHTGDGNFIYSQADENQKGKVARLVSPVVYSQNSAHCMTFWYHMSGSHVGTLRVKLRYQKPEEYDQLVWMAIGHQGDHWKEGRVLLHKSLKLYQVIFEGEIGKGNLGGIAVDDISINNHISQEDCAKPADLDKKNPEIKIDETGSTPGYEGEGEGDKNISRKPGNVLKTLDPILITIIAMSALGVLLGAVCGVVLYCACWHNGMSERNLSALENYNFELVDGVKLKKDKLNTQSTYSEA | Human | Can affect tumor cells directly in an autocrine manner | Proliferation and chemotaxis assays | PC3 | Prostate carcinoma | Not found |
| dbacp05526 | Phylloseptin-PBa1 | FLSLIPHIASGIASLVKNF | Burmeister's leaf frog, Brazil, South America | Disruption of cell membranes | MTT cell viability assay | PC3 | Prostate cancer | IC50 : approx. 0.29 µM |
| dbacp05537 | Phylloseptin-PBa2 | FLSLLPHIASGIASLVSKF | Burmeister's leaf frog, Brazil, South America | Disruption of cell membranes | MTT cell viability assay | PC3 | Prostate cancer | IC50 : approx. 0.50 µM |
| dbacp06064 | Shepherdin | KHSSGCAFL | Not found | Inducing apoptosis | MTT assay | PC3 | Prostate adenocarcinoma | IC50 : 25–75 µM |
| dbacp06068 | Shepherdin (ATP) | RQIKIWFQNRRMKWKKKHSSGCAFL | Not found | Inducing apoptosis | MTT assay | PC3 | Prostate adenocarcinoma | IC50 : 50–75 μM |
| dbacp06072 | Shepherdin (TAT) | YGRKKRRQRRRKHSSGCAFL | Not found | Inducing apoptosis | MTT assay | PC3 | Prostate adenocarcinoma | IC50 : 50–75 μM |